Cuenca-Pardo J, Luján OF, Castañeda RH

Language: Spanish
References: 50
Page: 6-12
PDF size: 109.63 Kb.

ABSTRACT

Obese people are very vulnerable and have a high risk level in their response to traumatism and disease. In the Burn Unit of the Traumatology Hospital «Victorio de la Fuente Narváez» of the IMSS, a comparative study was carried out with a total of 1,911 patients: 1,860 not obese (96.3%) (Group I) and 51 obese (3.7%) (Group II). The patients from group I, 0.8% did not know that they had a disease when suffered burn injury, and in group II, 96.1% did not know. The index (ABSI) for group I had an average of 6.05 and of 7.4 for group II, with a difference of 1.3 (p ‹ 0.002) Group I patients required 2.1 surgeries per patient. Group II required 3.5 surgeries per patient. There was a difference of 1.4 surgeries (p ‹ 0.019). Hospitalization for group I was 15.7 days and for group II hospitalization was 18.64 days. There was a difference of 2.94 days hospitalization (p ‹ 0.002). Burned obese patients had suffered more complications and death in comparison with not obese patients, with an estimated risk of 6.7 and 7.5 respectively. Obesity is one of the most severe factors in burned patients. Obese patients that suffer burn injuries show longer hospitalization and a higher number of surgeries as well as a higher risk for complications and death than a not obese patient.

REFERENCES

1. Bray GA. Contemporary diagnosis in management of obesity. New-Town Pa. Handbook in health care, 1998.

2. Tierney LM, Mc Phee SJ, Papadakis, Mocine A. Current: Medical diagnosis and treatment. International Edition. Ed. Lange 2000: 1222-1225.

3. Pi-Sunyer FX. Proc Obesity: criteria and classification. Nutr Soc 2000; 59(4): 505-509.

4. Rosenbaum M, Liebel L. Rudolph, Hirsch Jules. Obesity. N Engl J Med 1997; 337: 396.

5. Bray GA. Etiology and Pathogenesis of Obesity: Clinical Cornerstone. Excerpta Medica 1999; 2(3): 1-15.

6. Leslie M. Weighing in on clinical guidelines for obesity. Tools to assist your patients. Adv Nurse Pract 2000; 8(3): 78-81.

7. Chiprut R y cols. La obesidad en el siglo XXI. Avances en etiopatogenia y tratamiento. Gac Med Méx 2001; 137(4): 323-334.

8. Godínez-Gutiérrez SA. Alteraciones musculoesqueléticas y obesidad. Endocrinología y Nutrición 2001; 9(2): 86-90.

9. Darryl YS. Obesity and pulmonary function: More or Less? Chest 1997; 111(4): 844-845.

10. Susan ZY. Overweight, Obesity, and Health Risk. Arch Intern Med 2000; 160(7): 898-904.

11. Stevens J et al. The effect of age on the association between body- mass index and mortality. N Engl J Med 1998; 338: 1.

12. Clark JM, Brancati FL. The Challenge of Obesity-related Chronic Diseases. J Gen Intern Med 2000; 15(11): 828-829.

13. Expert Panel on Overweight and Obesity in adults. Arch Int Med 1998; 158 (17): 1855.

14. López-Alveranga JC y cols. Enfermedades Asociadas a la Obesidad. Endocrinología y Nutrición 2001; 9(2): 77-85.

15. Sánchez-Reyes L y cols. Incidencia de obesidad en una población mexicana. Endocrinología y Nutrición 2001; 9(2): 60-66.

16. Zárate A y cols. La obesidad: Conceptos actuales sobre fisiopatogenia y tratamiento. Rev Fac Med UNAM 2001; 44(2): 66-70.

17. Gómez-Dantes H y cols. Obesidad en adultos derechohabientes del IMSS. Encuesta Nacional de Salud 2000. Rev Med IMSS 2004; 42(3): 239-245.

18. Ray DE et al. The effect of body mass index on patient outcomes in a medical ICU. Chest 2005; 127(6): 2125-2131.

19. Neville AL et al. Obesity is an Independent risk factor of mortality in severely injured blunt trauma patients. Arch Surg 2004; 139(9): 983-987.

20. Bendlin A, Linares H, Benaim F. Tratado de Quemaduras. México: Interamericana McGraw-Hill 1993: 116-125.

21. Nguyen TT, Gilpin DA, Meyern NA, Rendón DN. Current treatment Burned patients. Ann Surg 1996; 225: 14-25.

22. Canon JG et al. Circulating interleukin-18 and tumour necrosis factor alpha concentrations after burn injury in humans. Crit Care Med 1992; 20: 1414-1419.

23. Grabosch A, Rokos H. Neopterin as parameter of cell-mediated immunity response in thermally injured patients. Burns 1992; 18: 113-116.

24. Ward PA, Till GO. Pathophysiologic events related to thermal injury of skin. J Trauma 1990; 30: 57-62.

25. Bonaldi L, Frank DH. Fisiopatología de las Quemaduras. En: Achauer B. Atención del paciente quemado. México: El Manual Moderno 1987: 21-50.

26. Solomkin JS. Neutrophil disorders in burns injury: complement, cytokines and organ injury. J Trauma 1990; 30: 80-85.

27. Trop M, Schiffrin EJ, Cartes EA. Effect of acute and chronic lipopolysaccharide (LPS) administration on reticuloendothelial system (RES) in vivo. Burns 1992; 18: 107-108.

28. Canon JG. Circulating interleukin-1 and tumor necrosis factor in septic shock and experimental endotoxin fever. J Inf Dis 1990; 161: 79-84.

29. Demling RH, Lalonde CH. Identification and modifications of the pulmonary and systemic inflammatory and biochemical changes caused by a skin burn. S J Trauma 1990; 30: 57-62.

30. Ryan CM, Yarmush ML, Burke JF, Tompkins RG. Increased gut permeability early after burns correlates with extent of burn injury. Crit Care Med 1992; 20: 1508-1512.

31. Magic Z. Effect of non-lethal scalding on the amount of DNA and RNA in rat liver. Burns 1986; 12: 172-175.

32. Yuesheng H, Li A, Zongcheng Y. A prospective clinical study on the pathogenesis of multiple organ failure in severely burned patients. Burns 1992; 18: 30-34.

33. Anderson BO, Harken AH. Multiple organ failure: inflammatory priming and activation sequences promote auto-logus tissue injury. J Trauma 1990; 30: 44-49.

34. Dickson PW, Bannister D. Minor burns lead to major changes in synthesis rates of plasma proteins in the liver. J Trauma 1987; 27: 79-84.

35. Herdon DN, Traber DL. Pulmonary circulation and burns and trauma. S J Trauma 1998; 30: 41-44.

36. Yang L, Hsu B. The roles of macrophage and PGE-2 in post burn immunosuppression. Burns 1992; 18: 132-136.

37. Maldonado MD, Venturoli A, Franco A, Núñez-Roldán A. Specific changes in peripheral blood lymphocyte phenotype from burn patients. Burns 1991; 17: 188-192.

38. Alexander JW. Mechanism of immunologic suppression in burn injury. J Trauma 1990; 30: 70-75.

39. Oldham K, Guice KT et al. Activation of complement by hydroxyl radical in thermal injury. Surgery 1988; 107: 272-279.

40. Sasaki J, Cottman G, Baxter C. Lipid peroxidation following thermal injury. J Burn Care Rehabil 1987; 4: 251-254.

41. Johnson CE, Granstrom E, Hamberg M. Prostaglandins and thromboxanes in burn injury in man. Scand J Plast Surg 1979; 13: 45.

42. Mandrup-Poulsen T et al. Circulating interleukin-1 receptor antagonist concentrations are increased in adult patient with thermal injury. Crit Care Med 1994; 23: 1.

43. Benaim F. Enfoque global del tratamiento de las quemaduras. En: Coiffmann F. Cirugía Plástica Reconstructiva y Estética. Masson y Salvat 1994: 443-496.

44. Bendlin A. Tratamiento inicial de las quemaduras graves. En: Bendlin A, Linares H, Benaim F. Tratado de quemaduras. México: Interamericana McGraw – Hill 1993: 149-160.

45. Garner W. Thermal Burns. In: Achauer B. Plastic surgery. Indications, Operations, and Outcomes. Philadelphia: Mosby 2000: 357-373.

46. Salisbury R. Thermal Burns. In: McCarthy J. Plastic Surgery. Philadelphia: W.B Saunders Co. 1990: 787-813.

47. Cuenca-Pardo J, Álvarez-Díaz CJ, Serrano Casillas JM. Fase inflamatoria en el paciente quemado. Cir Plast 2000; 11: 90-97.

48. Farrell RT, Gameli RL, Aleem RF, Sinacore JM. The relationship of body Mass Index and functional outcomes in patients with acute burns. J Burn Care Res 2008; 29: 102-108.

49. Tobiasen J, Hieben JM, Edlich RF. The abbreviate burn severity index. Ann Emerg Med 1982; 11: 260-272.

50. American Burn Association. Guidelines for Service Standards and Severity Classifications in the treatment of Burn injury. Am Coll Surg Bul 1984; 89: 24-28.